Phosphorylation of Arl4A/D promotes their binding by the HYPK chaperone for their stable recruitment to the plasma membrane

The Arl4 small GTPases participate in a variety of cellular events, including cytoskeleton remodeling, vesicle trafficking, cell migration, and neuronal development. Whereas small GTPases are typically regulated by their GTPase cycle, Arl4 proteins have been found to act independent of this canonica...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 119; no. 30; pp. 1 - 9
Main Authors Lin, Ming-Chieh, Yu, Chia-Jung, Lee, Fang-Jen S.
Format Journal Article
LanguageEnglish
Published Washington National Academy of Sciences 26.07.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The Arl4 small GTPases participate in a variety of cellular events, including cytoskeleton remodeling, vesicle trafficking, cell migration, and neuronal development. Whereas small GTPases are typically regulated by their GTPase cycle, Arl4 proteins have been found to act independent of this canonical regulatory mechanism. Here, we show that Arl4A and Arl4D (Arl4A/D) are unstable due to proteasomal degradation, but stimulation of cells by fibronectin (FN) inhibits this degradation to promote Arl4A/D stability. Proteomic analysis reveals that FN stimulation induces phosphorylation at S143 of Arl4A and at S144 of Arl4D. We identify Pak1 as the responsible kinase for these phosphorylations. Moreover, these phosphorylations promote the chaperone protein HYPK to bind Arl4A/D, which stabilizes their recruitment to the plasma membrane to promote cell migration. These findings not only advance a major mechanistic understanding of how Arl4 proteins act in cell migration but also achieve a fundamental understanding of how these small GTPases are modulated by revealing that protein stability, rather than the GTPase cycle, acts as a key regulatory mechanism.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author contributions: M.-C.L. and F.-J.S.L. designed research; M.-C.L. performed research; C.-J.Y. contributed new reagents/analytic tools and supported the experiments; M.-C.L. and F.-J.S.L. analyzed data; M.-C.L. and F.-J.S.L. wrote the paper.
Edited by Peter Novick, Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA; received April 29, 2022; accepted June 20, 2022
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.2207414119